Quanterix's core product portfolio centers around its proprietary Simoa (Single Molecule Array) technology platform, which includes automated instrument systems such as the HD-X and SR-X analyzers designed for ultra-sensitive digital immunoassay testing. The company also produces a vast catalog of specialized assay kits, reagents, and consumable consumables targeting specific neurological, oncological, and inflammatory biomarkers. Following its acquisition of Akoya Biosciences, the product lineup further encompasses advanced spatial biology instruments, multi-omic tissue imaging systems, and reagent kits for single-cell cellular analysis.